Anxiety’s Long-Term Impact on Dementia Development

FHS
July 26, 2024
9:38 am

The longitudinal relationship between chronic, resolved, and new onset anxiety and the risk of all-cause dementia (Progressive cognitive decline affecting memory and thinking).

Dizal presents updated PhII PTLC data, plans to file for accelerated approval in the US next year

Dizal said its peripheral T-cell lymphoma drug candidate showed positive efficacy and safety in a Phase II registrational trial, paving the way for a US

December 13, 2023

New technology could help amputees feel temperature in their phantom limbs

Johns Hopkins Applied Physics Laboratory (APL) researchers have developed one of the world’s smallest, most intense and fastest refrigeration devices, the wearable thin-film thermoelectric cooler

July 27, 2023

AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of PREVYMIS® (letermovir) in Second Indication – Biotech Investments

EQS-News: AiCuris Anti-infective Cures AG / Key word(s): Miscellaneous AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of

August 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.